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ABSTRACT
Objective: To evaluate the influence of endothelin-1 (ET-
1) and sex hormones on cell proliferation and extracellular
matrix (ECM) synthesis (ie, fibronectin, laminin) by
cultured normal and scleroderma (SSc) human skin
fibroblasts (FBs).
Methods: Primary cultures of FBs were treated with ET-1
and sex hormones (17b-oestradiol or testosterone) for
24 h. Cell growth was analysed by methiltetrazolium salt
test, ECM synthesis was evaluated by immunocyto-
chemistry and western blot, both at 24 h.
Results: In normal FBs, ET-1 and 17b-oestradiol, as well
as their combination, increased cell growth (p,0.001,
p,0.001, p,0.01 vs untreated cells (control), respec-
tively) and fibronectin synthesis (p,0.05, p,0.05,
p,0.01 vs control, respectively). By contrast, testoster-
one either alone or in combination with ET-1 did not
influence cell proliferation, but decreased fibronectin
synthesis (p,0.05, testosterone vs control). In SSc FBs,
ET-1 and 17b-oestradiol alone or their combination
induced an increased fibronectin synthesis (p,0.05,
p,0.05, p,0.01 vs control, respectively). Unexpectedly,
testosterone induced an increase of fibronectin synthesis
(p,0.05 vs control).
Conclusions: ET-1 and 17b-oestradiol seem to exert a
profibrotic effect in normal and SSc culture FBs and might
suggest their synergistic effect in the pathogenesis of the
fibrotic process in SSc.
Fibrosis is a pathological hallmark of several
connective tissue diseases including systemic
sclerosis (SSc), in which fibroblasts (FBs) are key
effectors of the fibrotic process through an
excessive production of extracellular matrix
(ECM) components in the skin and internal
organs.
1 Recent evidence suggests that endothe-
lin-1 (ET-1) plays an important role in the
pathogenesis of fibrosis by exerting a potent
mitogenic effect on FBs and increased ET-1
production in FBs derived from patients with SSc
has been found.
23 Moreover, increased ET-1
plasma levels are observed in patients with SSc.
4
Clinical and basic data suggest that oestrogens
may influence dermal tissue remodelling.
5
Oestrogens enhance the in vitro production by
FBs of basic fibroblast growth factor (BFGF) and
transforming growth factor (TGF)-b1, inducing
their proliferation, migration, production of the
CM and decreasing generation of tissue-degrading
matrix metalloproteinases .
67 In in vivo studies,
topical oestrogens increased collagen I and III
expression in the dermis.
8 Interestingly, from the
epidemiological evidence, SSc is found significantly
more frequently in women than men.
9
Inthe present study,weinvestigatedthe effects of
ET-1 on cultured human SSc and normal skin FBs,
and sex hormones on cell proliferation and ECM
synthesis (ie, fibronectin, laminin), in order to detect
possible synergistic effects on the fibrotic process.
MATERIALS AND METHODS
Cell cultures and treatments
Skin biopsies were obtained during diagnostic
procedures (Dermatological Clinic, University of
Genoa) from six patients with SSc (three women
and three men, mean (SD) aged 60 (4) years) and
from six healthy subjects (three women and three
men, mean (SD) age 55 (10) years), after informed
consent and ethical committee approval was
obtained. In order to reduce the variability, the
patients enrolled into the study showed similar
capillaroscopic pattern of microangiopathy (‘‘late’’
pattern), skin involvement (limited SSc), mean
(SD) disease duration (7 (3) years) and ongoing
treatments (buflomedil, aspirin, lansoprazole). SSc
control FBs obtained from the biopsies were plated
into flasks with RPMI-1640 medium supplemented
with 10% fetal bovine serum (FBS). The cells were
treated for 24 h in serum-free medium, with ET-1
having a mitogenic effect (10
27 M, Axxora,
Lo ¨rrach, Germany), physiological concentrations
of 17b-oestradiol (E2, 10
210 M, Sigma-Aldrich,
Milan, Italy) or testosterone (T, 10
29 M, Sigma-
Aldrich) alone and in combination with ET-1.
Untreated cells were used as controls.
In the preliminary stage of the study, we
generated a dose-response curve from normal FBs
for the agonists analysed in these experiments. For
ET-1 we tested a concentration range from 10
26 M
to 10
29 M, and at concentration of 10
27 M, the
cells showed an optimal mitogenic response. The
same approach was performed for E2 (range from
10
27 Mt o1 0
212 M) and T (range from 10
27 Mt o
10
212 M) resulting optimal concentrations of
10
210 M and 10
29 M, respectively. These concen-
trations are usually employed in in vitro studies.
The experiments were performed at24 h since the
serum-free culture condition was shown to signifi-
cantly influence the cell survival over longer time.
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) test
The MTT test was used to evaluate cell growth.
10
The FBs were plated into a 96-well tissue culture
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3 cells/well) and treated according to the
experimental design. At the established time, the cells were
incubated at 37uC, 5% CO2 in presence of MTT labelling
reagent (Promega Corporation, San Luis Obispo, California,
USA). Absorbance was measured at 492/620 nm. The experi-
ments were performed in triplicate.
Immunocytochemistry
FBs were cultured in Flexi PERM chamber slides (10610
3 cells/
spot) (Sartorius, Goettingen, Germany) and treated according to
the experimental design. At the end of treatment, the cells were
incubated with primary antibodies to human fibronectin
(Sigma-Aldrich; dilution 1:100), laminin (Sigma-Aldrich; dilu-
tion 1:100) and proliferating cell nuclear antigen (PCNA, Santa
Cruz Biotechnology, Santa Cruz, California, USA; dilution
1:200). Linked antibodies were detected by biotinylated
universal secondary antibody and subsequently horseradish
peroxidase–streptavidin complex (Vector Laboratories,
Burlingame, California, USA). The slide evaluation was
performed on 30 high-power fields for each condition by light
microscopy (magnification 406) and computerised image
analysis with the Leica Q500 MC Image Analysis System
(Leica, Wetzlar, Germany).
Western blot analysis
FBs, cultured up to 80% of confluence, were treated according to
the experimental design and lysed. For every condition, 0.02 g of
protein was separated by electrophoresis on a 10% sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
gel and transferred into Hybond-C-nitrocellulose membrane
(Amersham, Milan, Italy). Membranes were incubated in
Dulbecco phosphate buffered saline (DPBS)/5% powdered milk
with primary antibodies: anti-human PCNA (Santa Cruz
Biotechnology; dilution 1:200) as marker of cell proliferation;
anti-human fibronectin (Sigma-Aldrich; dilution 1:500) and anti-
laminin (Invitrogen, Carlsbad, California, USA; dilution 1:500) as
ECM proteins. Membranes were incubated with secondary
horseradish peroxidase-labelled polyclonal IgG antibody
(Amersham; dilution 1:5000), protein expression was detected
using the enhanced chemiluminescence system (Amersham).
Statistical analysis
The statistical analysis was carried out using non-parametric t
tests. The Wilcoxon test was performed to compare the paired
treatments. A probability value of p,0.05 was considered
statistically significant.
RESULTS
Effects of ET-1 and sex hormones on cell growth
ET-1, E2 alone or ET-1 and E2 in combination induced a
significant increase of cell proliferation (p,0.001; p,0.001;
p,0.01, respectively), whereas T alone or in combination with
ET-1 did not induced differences in normal human skin FBs
when compared to the untreated controls (vs control) (fig 1A).
The mean values between E2 and T differed significantly
(p,0.001) (fig 1A). By contrast, T in combination with ET-1
decreased the cell growth (p,0.01) when compared to ET-1-
treated FBs (fig 1A). These data were detected by the MTT test.
Cell growth was also evaluated by PCNA expression via
western blot analysis. ET-1, E2 alone or ET-1 and E2 in
combination were found to increase the PCNA expression vs
control. The opposite effect was observed in T-treated cells also
in the presence of ET-1 (fig 1B). Interestingly, no significant
differences were observed in SSc FBs (fig 1C). These results were
also confirmed by immunostaining for PCNA (data not shown).
Effects of ET-1 and sex hormones on ECM synthesis
Normal fibroblasts
ET-1 induced a significant increase of fibronectin synthesis
(p,0.05 vs control), whereas no significant difference for
Figure 1 A. Evaluation by 3-(4,5-dDimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) test of cell proliferation in human
normal fibroblasts (Fb) untreated (control) and treated for 24 h with
endothelin-1 (ET-1) (10
27 M), 17b-oestradiol (E2) (10
210 M), E2
(10
210 M) with ET-1 (10
27 M), testosterone (T) (10
29 M) or T (10
29 M)
with ET-1 (10
27 M). **p,0.01; ***p,0.001. B. Evaluation by western
blot analysis of proliferating cell nuclear antigen (PCNA) expression in
human normal Fb untreated (control) and treated for 24 h with ET-1
(10
27 M), E2 (10
210 M), E2 (10
210 M) with ET-1 (10
27 M), T (10
29 M) or
T (10
29 M) with ET-1 (10
27 M). C. Evaluation by MTT test of cell
proliferation in human systemic sclerosis fibroblasts (SSc Fb) untreated
(control) and treated for 24 h with ET-1 (10
27 M), E2 (10
210 M), E2
(10
210 M) with ET-1 (10
27 M), T (10
29 M) or T (10
29 M) with ET-1
(10
27 M).
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ET-1 induced a further significant increase for fibronectin
(p,0.05, p,0.01 vs control, respectively) and laminin
(p,0.05, p,0.05 vs control, respectively) (fig 2A,C).
Conversely, T was found to reduce the expression of both
ECM proteins: the decrease was significant for fibronectin
(p,0.05 vs control) in particular. The fibronectin synthesis was
also significantly reduced in FBs cultured in the presence of T
with ET-1 when compared to ET-1-treated cells (p,0.001)
(fig 2A). Interestingly, the mean values between E2 and T
differed significantly for fibronectin (p,0.001) and laminin
(p,0.001) synthesis (fig 2A,C). These data were obtained by
immunocytochemistry (ICC).
The ECM protein synthesis was also evaluated by western
blot. An evident change vs control was confirmed in particular
for the reduced fibronectin expression after T treatment (fig 2B).
SSc fibroblasts
ET-1 induced a significant increase of fibronectin and laminin
synthesis (p,0.05, p,0.05 vs control, respectively) (fig 2D,E).
Their synthesis was also significantly increased in E2 (p,0.01,
p,0.01 vs control, respectively) and E2 with ET-1-treated FBs
(p,0.01, p,0.01 vs control, respectively) (fig 2D,F).
Unexpectedly, T induced an increase of the ECM protein
expression thatwas significant forfibronectin (p,0.05 vscontrol)
(fig2D).Inaddition,the treatment withT and ET-1 was found to
induce a significant increase not only for fibronectin (p,0.05 vs
control) but also for laminin expression (p,0.05 vs control)
(fig 2D,F). These data were observed by ICC and confirmed by
western blot, in particular for fibronectin synthesis (fig 2E).
Finally, no statistically significant difference concerning cell
proliferation and ECM synthesis by FBs was found between
male and female patients with SSc, or in healthy subjects.
DISCUSSION
The present results indicate that ET-1 is able to increase
fibronectin synthesis in normal and SSc human skin FBs,
supporting a suggested important role of ET-1 in the pathogen-
esis of the fibrosis in SSc,
2–4 as well as in cell proliferation, but
limited to normal skin FBs. Interestingly, recent studies have
shown that ET-1 induces an increased expression of fibronectin
mRNA in cultured peritoneal mesothelial cells and contributes
to the ability of TGF-b to promote a profibrotic phenotype in
human FBs.
21 1 The prolonged vasoconstrictor activity and
profibrotic effect on FBs by ET-1 might contribute to the
pathogenesis of SSc.
Figure 2 Evaluation by immunocytochemistry (A) and western blot (B) of fibronectin (FN) expression in human normal fibroblasts (Fb) untreated
(control) and treated for 24 h with endothelin-1 (ET-1) (10
27 M), 17b-oestradiol (E2) (10
210 M), E2 (10
210 M) with ET-1 (10
27 M), testosterone (T)
(10
29 M) or T (10
29 M) with ET-1 (10
27 M). C. Evaluation by immunocytochemistry of laminin expression in human normal Fb untreated (control) and
treated for 24 h with ET-1 (10
27 M), E2 (10
210 M), E2 (10
210 M) with ET-1 (10
27 M), T (10
29 M) or T (10
29 M) with ET-1 (10
27 M). Evaluation by
immunocytochemistry (D) and western blot (E) of fibronectin expression in human systemic sclerosis (SSc) Fb untreated (control) and treated for 24 h
with ET-1 (10
27 M), E2 (10
210 M), E2 (10
210 M) with ET-1 (10
27 M), T (10
29 M) or T (10
29 M) with ET-1 (10
27 M). F. Evaluation by
immunocytochemistry of laminin expression in human SSc Fb untreated (control) and treated for 24 h with ET-1 (10
27 M), E2 (10
210 M), E2 (10
210 M)
with ET-1 (10
27 M), T (10
29 M) or T (10
29 M) with ET-1 (10
27 M). *p,0.05, **p,0.01, ***p,0.001.
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in the fibrotic process that characterise SSc.
12 13 Sex hormones
seem to play an important role in the modulation of immune/
inflammatory responses.
14 Growing evidence indicates that
oestrogens and androgens target human skin FBs, influencing
the wound repair processes, while elderly men heal wounds
more slowly than elderly women and show reduced matrix
deposition.
12 Moreover, E2 has been shown to increase fibroblast
proliferation and stimulate synthesis of collagen in women with
lower initial collagen levels.
8 Finally, oestrogen supplementation
in postmenopausal women increases skin thickness and collagen
content.
8 Therefore, since SSc is found more frequently in women
than men, the present study clearly supports the possible
enhancing effect of oestrogens on the SSc fibrotic process.
In particular, E2 increased cell growth, and fibronectin and
laminin synthesis in normal and SSc cultured FBs, indicating the
involvement of E2 as a possible enhancer of the fibrotic process.
In vivo, this action may be supported by growth factors (ie,
connective tissue growth factor (CTGF)) or cytokines, which
have been involved in ECM synthesis by SSc FBs.
1 By contrast,
no effect of T on normal fibroblast growth was observed and T
decreased fibronectin and laminin synthesis. These results seem
to support the anti-inflammatory effect of androgens already
observed in recent studies.
14 However, the unexpected enhance-
ment of fibronectin synthesis in T-treated SSc FBs, might well
be related to the increased oestrogen synthesis exerted by the
enhanced activity of aromatase in activated cells.
14 15 Aromatase
metabolises androgens into oestrogens, which increase the
intracrine effects on the cells.
14 15 The treatment of normal
and SSc FBs was performed with concentrations of sex
hormones and ET-1 on the basis of preliminary dose-response
curves resulting from testing normal FBs showing optimal cell
survival. However, the dose-response curve might be different
between SSc and control FBs, and this is a matter for further
analysis.
In addition, further studies on SSc FB sex hormone
metabolism might better explain the value of these early
observations and confirm the possible link between gender and
the fibrotic process. Real-time PCR analysis is ongoing, since
results from these tests may contribute strongly to confirming
these results.
In conclusion, the present study seems to support important
synergistic effects for ET-1 and 17b-oestradiol in the pathogen-
esis of the fibrotic process in SSc.
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